Influenza virus repurposes the antiviral protein IFIT2 to promote translation of viral mRNAs


Cells infected by influenza virus mount a large-scale antiviral response and most cells ultimately initiate cell-death pathways in an attempt to suppress viral replication. We performed a CRISPR–Cas9-knockout selection designed to identify host factors required for replication after viral entry. We identified a large class of presumptive antiviral factors that unexpectedly act as important proviral enhancers during influenza virus infection. One of these, IFIT2, is an interferon-stimulated gene with well-established antiviral activity but limited mechanistic understanding. As opposed to suppressing infection, we show in the present study that IFIT2 is instead repurposed by influenza virus to promote viral gene expression. CLIP‐seq demonstrated that IFIT2 binds directly to viral and cellular messenger RNAs in AU‐rich regions, with bound cellular transcripts enriched in interferon‐stimulated mRNAs. Polysome and ribosome profiling revealed that IFIT2 prevents ribosome pausing on bound mRNAs. Together, the data link IFIT2 binding to enhanced translational efficiency for viral and cellular mRNAs and ultimately viral replication. Our findings establish a model for the normal function of IFIT2 as a protein that increases translation of cellular mRNAs to support antiviral responses and explain how influenza virus uses this same activity to redirect a classically antiviral protein into a proviral effector.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Fig. 1: A CRISPR-knockout screen identifies the antiviral proteins IFIT2 and IFIT3 as proviral regulators of influenza virus infection.
Fig. 2: IFIT2 promotes IAV gene expression and progression through the viral life cycle.
Fig. 3: IFIT2 selectively binds AU-rich regions in viral and host mRNAs.
Fig. 4: IFIT2 associates with active ribosomes and increases the translational efficiency of viral mRNAs.
Fig. 5: IFIT2 modulates translational efficiency by preventing ribosome pausing.

Data availability

Data supporting the findings of the present study are available within the article and the Supplementary Tables, with the exception of raw data for eCLIP and ribosome profiling, which are accessible as BioProject PRJNA633047 containing BioSample accession nos. SAMN14931303 to SAMN14931312 and SRA accession nos. SRR11794832 to SRR11794851 (see Supplementary Table 6). All other data are available from the corresponding author upon reasonable request. Source data are provided with this paper.

Code availability

Existing code used for data analysis are described above. Customized code and pipelines are described and are available at or from the corresponding author upon request.


  1. 1.

    Iwasaki, A. & Pillai, P. S. Innate immunity to influenza virus infection. Nat. Rev. Immunol. 14, 315–328 (2014).

    CAS  PubMed  PubMed Central  Google Scholar 

  2. 2.

    Downey, J., Pernet, E., Coulombe, F. & Divangahi, M. Dissecting host cell death programs in the pathogenesis of influenza. Microbes Infect. 20, 560–569 (2018).

    CAS  PubMed  PubMed Central  Google Scholar 

  3. 3.

    Krammer, F. et al. Influenza. Nat. Rev. Dis. Prim. 4, 3 (2018).

    PubMed  Google Scholar 

  4. 4.

    Wang, D., Zhu, W., Yang, L. & Shu, Y. The epidemiology, virology, and pathogenicity of human infections with avian influenza viruses. Cold Spring Harb. Perspect. Med. (2020).

  5. 5.

    Long, J. S., Mistry, B., Haslam, S. M. & Barclay, W. S. Host and viral determinants of influenza A virus species specificity. Nat. Rev. Microbiol. 17, 67–81 (2019).

    CAS  PubMed  Google Scholar 

  6. 6.

    Carette, J. E. E. et al. Haploid genetic screens in human cells identify host factors used by pathogens. Science 326, 1231–1235 (2009).

    CAS  PubMed  Google Scholar 

  7. 7.

    Heaton, B. E. et al. A CRISPR activation screen identifies a pan-avian influenza virus inhibitory host factor. Cell Rep. 20, 1503–1512 (2017).

    CAS  PubMed  PubMed Central  Google Scholar 

  8. 8.

    Li, B. et al. Genome-wide CRISPR screen identifies host dependency factors for influenza A virus infection. Nat. Commun. 11, 164 (2020).

    CAS  PubMed  PubMed Central  Google Scholar 

  9. 9.

    Han, J. et al. Genome-wide CRISPR/Cas9 screen identifies novel host factors essential for influenza virus replication. Cell Rep. 23, 596–607 (2018).

    CAS  PubMed  PubMed Central  Google Scholar 

  10. 10.

    Schaack, G. A. & Mehle, A. Experimental approaches to identify host factors important for influenza virus. Cold Spring Harb. Perspect. Med. (2019).

  11. 11.

    Hao, L. et al. Drosophila RNAi screen identifies host genes important for influenza virus replication. Nature 454, 890–893 (2008).

    CAS  PubMed  PubMed Central  Google Scholar 

  12. 12.

    Diamond, M. S. & Farzan, M. The broad-spectrum antiviral functions of IFIT and IFITM proteins. Nat. Rev. Immunol. 13, 46–57 (2013).

    CAS  PubMed  Google Scholar 

  13. 13.

    Fensterl, V. & Sen, G. C. Interferon-induced ifit proteins: their role in viral pathogenesis. J. Virol. 89, 2462–2468 (2015).

    PubMed  Google Scholar 

  14. 14.

    Li, Y. et al. ISG56 is a negative-feedback regulator of virus-triggered signaling and cellular antiviral response. Proc. Natl Acad. Sci. USA 106, 7945–7950 (2009).

    CAS  PubMed  Google Scholar 

  15. 15.

    Pichlmair, A. et al. IFIT1 is an antiviral protein that recognizes 5′-triphosphate RNA. Nat. Immunol. 12, 624–630 (2011).

    CAS  PubMed  Google Scholar 

  16. 16.

    Daffis, S. et al. 2′-O-methylation of the viral mRNA cap evades host restriction by IFIT family members. Nature 468, 452–456 (2010).

    CAS  PubMed  PubMed Central  Google Scholar 

  17. 17.

    Schoggins, J. W. et al. Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity. Nature 505, 691–695 (2014).

    CAS  PubMed  Google Scholar 

  18. 18.

    Szretter, K. J. et al. 2′-O-methylation of the viral mRNA cap by West Nile virus evades Ifit1-dependent and -independent mechanisms of host restriction in vivo. PLoS Pathog. 8, e1002698 (2012).

    CAS  PubMed  PubMed Central  Google Scholar 

  19. 19.

    Terenzi, F., Saikia, P. & Sen, G. C. Interferon-inducible protein, P56, inhibits HPV DNA replication by binding to the viral protein E1. EMBO J. 27, 3311–3321 (2008).

    CAS  PubMed  PubMed Central  Google Scholar 

  20. 20.

    Fensterl, V. et al. Interferon-induced Ifit2/ISG54 protects mice from lethal VSV neuropathogenesis. PLoS Pathog. 8, e1002712 (2012).

  21. 21.

    Pinto, A. K. et al. Human and murine IFIT1 proteins do not restrict infection of negative-sense RNA viruses of the Orthomyxoviridae, Bunyaviridae, and Filoviridae families. J. Virol. 89, 9465–9476 (2015).

    CAS  PubMed  PubMed Central  Google Scholar 

  22. 22.

    Daugherty, M. D., Schaller, A. M., Geballe, A. P. & Malik, H. S. Evolution-guided functional analyses reveal diverse antiviral specificities encoded by IFIT1 genes in mammals. eLife 5, e14228 (2016).

    PubMed  PubMed Central  Google Scholar 

  23. 23.

    Stawowczyk, M., Van Scoy, S., Kumar, K. P. & Reich, N. C. The interferon stimulated gene 54 promotes apoptosis. J. Biol. Chem. 286, 7257–7266 (2011).

    CAS  PubMed  Google Scholar 

  24. 24.

    Fleith, R. C. et al. IFIT3 and IFIT2/3 promote IFIT1-mediated translation inhibition by enhancing binding to non-self RNA. Nucleic Acids Res. 46, 5269–5285 (2018).

    CAS  PubMed  PubMed Central  Google Scholar 

  25. 25.

    Johnson, B. et al. Human IFIT3 modulates IFIT1 RNA binding specificity and protein stability. Immunity 48, 487–499 (2018).

    CAS  PubMed  PubMed Central  Google Scholar 

  26. 26.

    Benitez, A. A. et al. In vivo RNAi screening identifies MDA5 as a significant contributor to the cellular defense against influenza A virus. Cell Rep. 11, 1714–1726 (2015).

    CAS  PubMed  PubMed Central  Google Scholar 

  27. 27.

    Tran, V., Moser, L. A., Poole, D. S. & Mehle, A. Highly sensitive real-time in vivo imaging of an influenza reporter virus reveals dynamics of replication and spread. J. Virol. 87, 13321–13329 (2013).

    CAS  PubMed  PubMed Central  Google Scholar 

  28. 28.

    Tran, V. et al. Multi-modal imaging with a toolbox of influenza a reporter viruses. Viruses 7, 5319–5327 (2015).

    CAS  PubMed  PubMed Central  Google Scholar 

  29. 29.

    Yang, Z. et al. Crystal structure of ISG54 reveals a novel RNA binding structure and potential functional mechanisms. Cell Res. 22, 1328–1338 (2012).

    CAS  PubMed  PubMed Central  Google Scholar 

  30. 30.

    Takizawa, T. et al. Induction of programmed cell death (apoptosis) by influenza virus infection in tissue culture cells. J. Gen. Virol. 74 (Pt 11), 2347–2355 (1993).

    CAS  PubMed  Google Scholar 

  31. 31.

    Mühlbauer, D. et al. Influenza virus-induced caspase-dependent enlargement of nuclear pores promotes nuclear export of viral ribonucleoprotein complexes. J. Virol. 89, JVI.03531–14 (2015).

    Google Scholar 

  32. 32.

    Wurzer, W. J. et al. Caspase 3 activation is essential for efficient influenza virus propagation. EMBO J. 22, 2717–2728 (2003).

    CAS  PubMed  PubMed Central  Google Scholar 

  33. 33.

    Ingolia, N. T., Lareau, L. F. & Weissman, J. S. Ribosome profiling of mouse embryonic stem cells reveals the complexity and dynamics of mammalian proteomes. Cell 147, 789–802 (2011).

    CAS  PubMed  PubMed Central  Google Scholar 

  34. 34.

    Wolin, S. L. & Walter, P. Ribosome pausing and stacking during translation of a eukaryotic mRNA. EMBO J. 7, 3559–3569 (1988).

    CAS  PubMed  PubMed Central  Google Scholar 

  35. 35.

    Mar, K. B. et al. LY6E mediates an evolutionarily conserved enhancement of virus infection by targeting a late entry step. Nat. Commun. 9, 3603 (2018).

    PubMed  PubMed Central  Google Scholar 

  36. 36.

    Seo, J., Yaneva, R., Hinson, E. R. & Cresswell, P. Human cytomegalovirus directly induces the antiviral protein viperin to enhance infectivity. Science 332, 1097–1100 (2011).

    Google Scholar 

  37. 37.

    Xie, M. et al. Human cytomegalovirus exploits interferon-induced transmembrane proteins to facilitate morphogenesis of the virion assembly compartment. J. Virol. 89, 3049–3061 (2015).

    CAS  PubMed  Google Scholar 

  38. 38.

    Peretti, A. et al. Characterization of BK polyomaviruses from kidney transplant recipients suggests a role for APOBEC3 in driving in-host virus evolution. Cell Host Microbe 23, 628–635 (2018).

    CAS  PubMed  PubMed Central  Google Scholar 

  39. 39.

    Kim, E.-Y. et al. Human APOBEC3 induced mutation of human immunodeficiency virus type-1 contributes to adaptation and evolution in natural infection. PLoS Pathog. 10, e1004281 (2014).

    PubMed  PubMed Central  Google Scholar 

  40. 40.

    Mulder, L. C. F., Harari, A. & Simon, V. Cytidine deamination induced HIV-1 drug resistance. Proc. Natl Acad. Sci. USA 105, 5501–5506 (2008).

    CAS  PubMed  Google Scholar 

  41. 41.

    Cho, H., Shrestha, B., Sen, G. C. & Diamond, M. S. A role for Ifit2 in restricting West Nile virus infection in the brain. J. Virol. 87, 8363–8371 (2013).

    CAS  PubMed  PubMed Central  Google Scholar 

  42. 42.

    Sanjana, N. E., Shalem, O. & Zhang, F. Improved vectors and genome-wide libraries for CRISPR screening. Nat. Methods 11, 783–784 (2014).

    CAS  PubMed  PubMed Central  Google Scholar 

  43. 43.

    Shalem, O. et al. Genome-scale CRISPR-Cas9 knockout screening in human cells. Science 343, 84–87 (2014).

    CAS  PubMed  Google Scholar 

  44. 44.

    Doench, J. G. et al. Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9. Nat. Biotechnol. 34, 184–191 (2016).

    CAS  PubMed  PubMed Central  Google Scholar 

  45. 45.

    Mondal, A. et al. Influenza virus recruits host protein kinase C to control assembly and activity of its replication machinery. eLife 6, e26910 (2017).

    PubMed  PubMed Central  Google Scholar 

  46. 46.

    Richardson, S. M., Wheelan, S. J., Yarrington, R. M. & Boeke, J. D. GeneDesign: rapid, automated design of multikilobase synthetic genes. Genome Res. 16, 550–556 (2006).

    CAS  PubMed  PubMed Central  Google Scholar 

  47. 47.

    Dos Santos Afonso, E., Escriou, N., Leclercq, I., van der Werf, S. & Naffakh, N. The generation of recombinant influenza A viruses expressing a PB2 fusion protein requires the conservation of a packaging signal overlapping the coding and noncoding regions at the 5′ end of the PB2 segment. Virology 341, 34–46 (2005).

    PubMed  Google Scholar 

  48. 48.

    Karlsson, E. A. et al. Visualizing real-time influenza virus infection, transmission and protection in ferrets. Nat. Commun. 6, 6378 (2015).

    CAS  PubMed  PubMed Central  Google Scholar 

  49. 49.

    Reuther, P. et al. Generation of a variety of stable Influenza A reporter viruses by genetic engineering of the NS gene segment. Sci. Rep. 5, 11346 (2015).

    CAS  PubMed  PubMed Central  Google Scholar 

  50. 50.

    Watanabe, T., Watanabe, S., Noda, T., Fujii, Y. & Kawaoka, Y. Exploitation of nucleic acid packaging signals to generate a novel influenza virus-based vector stably expressing two foreign genes. J. Virol. 77, 10575–10583 (2003).

    CAS  PubMed  PubMed Central  Google Scholar 

  51. 51.

    Afgan, E. et al. The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2016 update. Nucleic Acids Res. 8, W3–W10 (2016).

  52. 52.

    Li, W. et al. MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens. Genome Biol. 15, 554 (2014).

    PubMed  PubMed Central  Google Scholar 

  53. 53.

    Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet J. 17, 10–12 (2011).

    Google Scholar 

  54. 54.

    Yang, Z. et al. Fast and sensitive detection of indels induced by precise gene targeting. Nucleic Acids Res. 43, e59 (2015).

    PubMed  PubMed Central  Google Scholar 

  55. 55.

    Yewdell, J. W. & Gerhard, W. Antigenic characterization of viruses by monoclonal antibodies. Annu. Rev. Microbiol. 35, 185–206 (1981).

    CAS  PubMed  Google Scholar 

  56. 56.

    Huppertz, I. et al. iCLIP: protein–RNA interactions at nucleotide resolution. Methods 65, 274–287 (2014).

    CAS  PubMed  PubMed Central  Google Scholar 

  57. 57.

    Van Nostrand, E. L. et al. Robust transcriptome-wide discovery of RNA-binding protein binding sites with enhanced CLIP (eCLIP). Nat. Methods 13, 508–514 (2016).

    PubMed  PubMed Central  Google Scholar 

  58. 58.

    Kutluay, S. B. et al. Global changes in the RNA binding specificity of HIV-1 gag regulate virion genesis. Cell 159, 1096–1109 (2014).

    CAS  PubMed  PubMed Central  Google Scholar 

  59. 59.

    Heinz, S. et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 38, 576–589 (2010).

    CAS  PubMed  PubMed Central  Google Scholar 

  60. 60.

    Bushnell, B. BBMap v.37.75 (2015);

  61. 61.

    Lovci, M. T. et al. Rbfox proteins regulate alternative mRNA splicing through evolutionarily conserved RNA bridges. Nat. Struct. Mol. Biol. 20, 1434–1442 (2013).

    CAS  PubMed  PubMed Central  Google Scholar 

  62. 62.

    Quinlan, A. R. & Hall, I. M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841–842 (2010).

    CAS  PubMed  PubMed Central  Google Scholar 

  63. 63.

    Ramírez, F. et al. High-resolution TADs reveal DNA sequences underlying genome organization in flies. Nat. Commun. 9, 189 (2018).

    PubMed  PubMed Central  Google Scholar 

  64. 64.

    Ge, S. X., Jung, D. & Yao, R. ShinyGO: a graphical gene-set enrichment tool for animals and plants. Bioinformatics 36, 2626–2629 (2019).

    Google Scholar 

  65. 65.

    Kawakami, E. et al. Strand-specific real-time RT-PCR for distinguishing influenza vRNA, cRNA, and mRNA. J. Virol. Methods 173, 1–6 (2011).

    CAS  PubMed  Google Scholar 

  66. 66.

    Kiselak, E. A. et al. Transcriptional regulation of an axonemal central apparatus gene, sperm-associated antigen 6, by a SRY-related high mobility group transcription factor, S-SOX5. J. Biol. Chem. 285, 30496–30505 (2010).

    CAS  PubMed  PubMed Central  Google Scholar 

  67. 67.

    Ingolia, N. T., Brar, G. A., Rouskin, S., McGeachy, A. M. & Weissman, J. S. The ribosome profiling strategy for monitoring translation in vivo by deep sequencing of ribosome-protected mRNA fragments. Nat. Protoc. 7, 1534–1550 (2012).

    CAS  PubMed  PubMed Central  Google Scholar 

  68. 68.

    Guo, H., Ingolia, N. T., Weissman, J. S. & Bartel, D. P. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466, 835–840 (2010).

    CAS  PubMed  PubMed Central  Google Scholar 

  69. 69.

    Kim, D., Langmead, B. & Salzberg, S. L. HISAT: a fast spliced aligner with low memory requirements. Nat. Methods 12, 357–360 (2015).

    CAS  PubMed  PubMed Central  Google Scholar 

  70. 70.

    Dunn, J. G. & Weissman, J. S. Plastid: nucleotide-resolution analysis of next-generation sequencing and genomics data. BMC Genom. 17, 958 (2016).

    Google Scholar 

  71. 71.

    Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923–930 (2014).

    CAS  PubMed  Google Scholar 

  72. 72.

    Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139–140 (2010).

    CAS  Google Scholar 

  73. 73.

    Sheets, M. D., Fritz, B., Hartley, R. S. & Zhang, Y. Polyribosome analysis for investigating mRNA translation in Xenopus oocytes, eggs and embryos. Methods 51, 152–156 (2010).

    CAS  PubMed  PubMed Central  Google Scholar 

  74. 74.

    Mayeur, G. L., Fraser, C. S., Peiretti, F., Block, K. L. & Hershey, J. W. B. Characterization of eIF3k: a newly discovered subunit of mammalian translation initiation factor elF3. Eur. J. Biochem. 270, 4133–4139 (2003).

    CAS  PubMed  Google Scholar 

  75. 75.

    Gantt, K. R., Jain, R. G., Dudek, R. W. & Pekala, P. H. HuB localizes to polysomes and alters C/EBP-beta expression in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 313, 619–622 (2004).

    CAS  PubMed  Google Scholar 

  76. 76.

    Panda, A. C., Martindale, J. L. & Gorospe, M. Polysome fractionation to analyze mRNA distribution profiles. Bio. Protoc. 7, e2126 (2017).

    PubMed  PubMed Central  Google Scholar 

Download references


This work was supported by the National Institutes of Health (NIH, grant nos. R21AI125897 and R01AI125271), the UW2020:WARF Discovery Initiative and a Shaw scientist award to A.M., an NIH National Service Award (no. T32 GM07215) to V.T., National Science Foundation grants (nos. GRFP DGE-1747503 to M.P.L., R01AI104972 to M.S.D and R01AI118938 to A.C.B.), the German Research Foundation (grant no. SFB 1160, project 13) to M.S., the Excellence Initiative of the German Research Foundation (GSC-4, Spemann Graduate School) and the Ministry for Science, Research and Arts of the State of Baden-Wuerttemberg to T.T., no. U19AI106754 to C.B. and no. HHSN272201400008C of the Center for Research on Influenza Pathogenesis, an NIAID-funded Center of Excellence for Influenza Research and Surveillance, and no. U19AI135972 to A.G.-S. A.M. holds an Investigators in the Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund. We thank D. Poole for technical assistance, members of the Mehle laboratory, M. Harrison, M. Sheets, C. Fraser, S. Floor and J. D. Sauer for valuable input, and C. Li, N. Reich, P. Friesen, Y. Kawaoka, L. Ristow and R. Welch for sharing reagents. We thank F. Zheng for reagents deposited in Addgene and the University of Wisconsin Biotechnology Center DNA Sequencing Facility for sequencing and IDAA services.

Author information




V.T. performed the CRISPR–Cas9 screen with WSN, MaGECK analysis and validation experiments. M.P.L. performed IFIT2 CLIP-seq and validation, polysome profiling, ribosome sequencing and analysis of CLIP-seq and ribosome-sequencing data. T.T. performed the CRISPR–Cas9 screen with SC35M. C.A.H. performed IFIT2 reporter assays. S.T. contributed methodology. M.W.C. performed the analysis of the screen with SC35M. C.B. supervised the SC35M analysis and contributed HOMER analysis. A.G.-S. and M.S. supervised the study. A.C.M.B. and M.S.D. contributed conceptualization and reagents. A.M. performed biochemistry and supervised the study.

Corresponding author

Correspondence to Andrew Mehle.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Peer review information Peer reviewer reports are available.

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Extended data

Extended Data Fig. 1 Enrichment of IFIT2 and IFIT3 over sequential influenza virus selections.

a, Schematic for hit analysis and selection. b-c, Frequency distribution of sgRNAs present in the parental libraries and those following selection with WSN (b) or SC35M (c). df, sgRNA enrichment trajectories following (d) sequential IAV-G selections, (e) IAV-G followed by bona fide influenza virus (WSN) infection or (f) selection with SC35M-GFP. The abundance of each sgRNA targeting the indicated gene is shown. g, Overlap between top hits from each screen. A conservative cut-off of RRA<10-5 was used to define top hits.

Extended Data Fig. 2 Characterization of replication and protein expression in the presence or absence of IFIT2 or IFIT3.

a, Two IFIT2-/- clones were created in A549 cells by CRISPR/Cas9 mutagenesis using distinct sgRNAs. Homozygous knockouts were identified by IDAA (indel detection by amplicon analysis). Chromatographs are shown for WT and mutant amplicons from IFIT2 knockout line #1 targeting AGAACGCCATTGACCCTCTG and IFIT2 knockout line #2 targeting GGCCAGTAGGTTGCACATTG. Size standards appear in red and amplicon peaks are shown in blue with calculated sizes in nucleotides listed above each peak. b, Ifit2-/- MEFS survive infection. WT and knockout cells were challenged with WSN or IAV stably encoding VSV-G (IAV-G). Surviving cells were visualized by staining with crystal violet. c, Kinetics of IFIT2 and NP expression were determined by infecting A549 cells with WSN (MOI = 0.2) and measuring protein expression by western blotting samples acquired at the indicated times post-infection. d, Clonal WT or IFIT2-/- 293 cells were infected with an IAV (WSN) reporter virus at an MOI = 0.01 and viral gene expression was measured 8 hpi. Each point represents mean gene expression (n = 4) from 4 independent clonal knockout lines. The mean of all lines is shown as a gray bar ± SEM. e, IFIT2 was expressed in WT 293 cells (clonal line 1B8) or IFIT2-/- knockout 293 cells (clonal line 3B9) for 12 hr followed by infection with an IAV (WSN) reporter virus (MOI = 0.1) for 8 hr. n = 2 independent infections. f, Two homozygous IFIT3-/- clones were identified by IDAA. Chromatographs are shown for WT and mutant amplicons from IFIT3 knockout lines #1 and #2 targeting CACTGCGGAGGACATCTGTT. Size standards appear in red and amplicon peaks are shown in blue with calculated sizes in nucleotides listed above each peak. g, Infection-induced IFIT3 expression was monitored in WT and IFIT3 knockout cells by western blotting. h, Multi-cycle replication of WSN in wildtype or IFIT3 knockout A549 human lung cells. Data represent mean ± standard deviation (n = 3 independent infections). i, Viral gene expression in wildtype or IFIT3 knockout cells infected with an influenza reporter virus for the indicated times. Data represent mean + sd (n = 4 independent infections). (*** p < 0.001; two-tailed Student’s t-test for pairwise comparisons between control and knockout clonal lines in d; * p < 0.05; ** p < 0.01 one-way ANOVA with post hoc Tukey’s HSD for e, h and i). Source data

Extended Data Fig. 3 Human IFIT2 and murine Ifit2 promote virus-induced apoptosis.

a, Caspase 3/7 activity was measured in wildtype, Ifit2-/-, and Bak/Bax-/- MEFs infected with WSN at an MOI of 0.01 for the indicated times. n = 4 independent infections ± standard deviation. b, Expression of cleaved (C-PARP) versus full-length (FL-PARP) PARP-1 in IAV infected A549 and IFIT2 knockout cell lines. Protein bands were quantified and the percent C-PARP of total PARP signal normalized to a tubulin loading control is indicated below. c, Viability of Ifit2-/- cells during infection with WSN assessed by CellTiter Glo Assay at the indicated time points. n = 4 independent infections ± standard deviation. d, Multicycle replication of WSN reporter virus in in WT, Ifit2-/-, and Bak/Bax-/- MEFs. n = 3 independent infections ± standard deviation. e, Single-cycle WSN reporter virus gene expression at early time points post-infection in WT, Ifit2-/-, and Bak/Bax-/- MEFs. n = 4 independent infections ± standard deviation. f, WSN reporter virus gene expression in Bak/Bax-/- cells ectopically expressing an empty vector, hIFIT2, or hIFIT2-ΔRNA. n = 3 independent infections ± standard deviation. *p < 0.05, **p < 0.01; *** p < 0.001; Two-tailed Student’s T-test for pairwise comparisons (c) or one-way ANOVA with post hoc Tukey’s HSD for multiple comparisons to WT cells (a, d, e and f). All data are plotted as mean ± sd. Source data

Extended Data Fig. 4 Analysis of IFIT2 CLIP-Seq data.

a, Experimental workflow for eCLIP of IFIT2 from IAV WSN-infected A549 cells. RNA-protein adducts were formed in infected cells by UV cross-linking. Lysates were prepared and RNA was partially digested with RNase. A fraction of lysate was removed to serve as the size-matched input control (SM input). IFIT2 was immunopurified and bound RNAs were processed via eCLIP followed by sequencing and analysis. b, CLIP-Seq was performed in duplicate and compared for IFIT2 CLIP or size-matched input (SMI) controls. Pearson’s correlation coefficient is shown as a heatmap. c, Concordance between ranked peaks in two independent biological replicates of IFIT2 CLIP-Seq was assessed by calculating an irreproducible discover rate (IDR). A conservative threshold of 5% was used to identify significant peaks. d, Abundance distribution in the size-matched input control for all transcripts and those with IFIT2 CLIP peaks. Populations were compared by a two-sided Mann-Whitney U-test. e, Meta-analysis of GC content for peaks identified in the 5’ UTR and coding sequence (CDS) of bound transcripts. IFIT2-bound RNAs were compared to all expressed 5’ UTRs or CDS via a two-sided Mann-Whitney U-test. f, A degenerate UAGnnUAU motif was found in ~20% of IFIT2 CLIP peaks (p = 10-279 compared to background).

Extended Data Fig. 5 IFIT2 binds viral mRNA but not genomic vRNA.

a, IFIT2 CLIP-Seq was performed on WSN infected cells. Reads were mapped to viral mRNA (top) or genomic vRNA (bottom) and analyzed with CLIPper. No CLIP peaks were identified on the genomic RNA. Data from biological duplicates of size-matched input controls or IFIT2 CLIP are plotted as mean and standard deviation using dark and light shades of the same color, respectively. BPM = bins per million. b, Western blot of immunoprecipitated IFIT2 or IgG controls used for RIP-qRT-PCR shown in Fig. 3e. c, Recombinant HisGST-IFIT2 used for EMSA analysis in Fig. 3f was expressed and purified from E. coli. Protein integrity and purity was verified by gel electrophoresis and Coomassie staining. IFIT2∆RNA = R212E/K410E mutant. Source data

Extended Data Fig. 6 IFIT2 enhances the translational efficiency of influenza virus NP mRNA.

ac, Full dataset underlying results presented in Fig. 4d. Polysome profiling was performed on WT and IFIT2-/- A549 cells infected with WSN. a, The polysome profile is shown again for clarity. b, qRT-PCR quantification of β-actin or c, NP mRNA in each fraction. The sum of less efficiently translated mRNA present in “light” polysome fractions (5 or less ribosomes per message) or efficiently translated mRNA in “heavy” polysome fractions (>5 ribosomes per message) is shown under each trace. Loss of IFIT2 shifts NP mRNA towards the top of the gradient, indicating less efficient translation than in WT cells. d, IFIT2-/- 293 cells or two clones of WT cells were transfected with an IFIT2 expression vector or an empty vector control prior to infection with WSN. Proteins were detected by western blot. Source data

Extended Data Fig. 7 Loss of IFIT2 results in ribosomal pausing that decreases translation and increases pausing of IFIT2-bound mRNAs.

Ribosome dynamics were monitored in cells infected with IAV WSN. a, The translational efficiency of IFIT2-bound ISG mRNAs is decreased in the absence of IFIT2. Bound transcripts were compared to unbound transcripts via a two-sided Mann-Whitney U-test. b-c, Accumulation of paused ribosomes in the absence of IFIT2. Normalized read density for total RNA (top) and ribosome-protected fragments (RPFs) (bottom) mapping to IAV mRNAs (b) or GAPDH (c) in infected WT and IFIT2-/-cells. A close-up view of NP is shown in Fig. 5c. Data from replicate experiments are plotted as mean and standard deviation using dark and light shades of the same color, respectively. Pause sites are shown below. Pause sites enriched in IFIT2-/- cells >1.5-fold are filled in. High coverage at the 5’ and 3’ end of PB2, PB1 and PA is consistent with low levels of defective-interfering (DI) particles commonly found in laboratory viral stocks. Note that there are no IFIT2-dependent pause sites identified on GAPDH mRNA. BPM = bins per million. d, Ribosome pausing increases during infection of IFIT2-/- cells. Changes in pause intensity (pauseI) between the maximum and minimum pauseI sites on each transcript were calculated during infection of WT and IFIT2-/- cells. e, Transcripts contain multiple pause sites. The pause sites with the minimum, median and maximum pauseI were identified. The effect of IFIT2 on pausing for each of these classes was determined by comparing IFIT2-bound transcripts to unbound transcripts. In the absence of IFIT2, pauseI increases at the strongest pause sites (maximum) while it is reduced at the weakest pause sites (minimum). The median pause sites are unchanged. f, Increased pausing and decreased translation are correlated for IFIT2-bound mRNAs. The relationship between pausing and translation efficiency was assessed by calculating a pause-TE index (pauseImax/TE) for each transcript. Changes in the pause-TE index were assessed for IFIT2-bound mRNAs (left), IAV mRNAs (middle), and ISG mRNAs (right). Comparisons in (df) were performed via a two-sided Mann-Whitney U-test.

Extended Data Fig. 8 Sequence-dependent enhancement of NP translation in the presence of IFIT2.

a, Diagram of NP-2A-GFP polyprotein. For cell-based assays in Fig. 5f, NP was expressed as a polyprotein where NP was separated from GFP by the 2A cleavage sequence from porcine teschovirus. NP is shaded to represent the codon juggling that introduced silent mutations to NPjug. See Methods for details. b, NP was expressed in 293T cells from a gene encoding WT or juggled codons for only NP, and not a polyprotein. IFIT2-V5 was co-expressed where indicated. Expression was detected by western blot, including Hsp90 as a loading control. Source data

Extended Data Fig. 9 Classic “antiviral” proteins can be re-purposed during infection into pro-viral effectors.

A model for the dichotomous functions of IFIT2. IFIT2 enhances translation of host mRNAs, including ISGs, to exert antiviral activity to diverse viruses. Yet, as shown here, IFIT2 is re-purposed during influenza virus infection to increase translation of viral mRNAs and shift the balance resulting in a net increase in viral mRNA translation and viral replication.

Extended Data Fig. 10 Replication kinetics of recombinant B/Brisbane/60/2008 and the reporter virus B/Brisbane/60/2008-PASTN.

An influenza B reporter virus encoding NanoLuc in the PA gene segment (see Methods for details). Infections were performed in MDCK cells (MOI = 0.01) at 33 ˚C and viral titers were determined by plaque assay at the indicated time points. Data are mean of n = 3 independent infection ± standard deviation.

Supplementary information

Reporting summary

Peer review file

Supplementary Table 1

MaGECK analysis of cells selected with WSN.

Supplementary Table 2

MaGECK analysis of cells selected with SC35M.

Supplementary Table 3

IFIT2-bound transcripts.

Supplementary Table 4

Changes in ribosome occupancy in IFIT2-knockout cells.

Supplementary Table 5

IFIT2-dependent ribosomal pausing.

Supplementary Table 6

Statistics and accession nos. for sequencing data.

Source data

Source Data Fig. 1

Unprocessed western blots for Fig. 1.

Source Data Fig. 3

Unprocessed western blots for Fig. 3.

Source Data Fig. 4

Unprocessed western blots for Fig. 4.

Source Data Extended Data Fig. 2

Unprocessed western blots for Extended Data Fig. 2.

Source Data Extended Data Fig. 3

Unprocessed western blots for Extended Data Fig. 3.

Source Data Extended Data Fig. 5

Unprocessed western blots for Extended Data Fig. 5.

Source Data Extended Data Fig. 6

Unprocessed western blots for Extended Data Fig. 6.

Source Data Extended Data Fig. 8

Unprocessed western blots for Extended Data Fig. 8.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Tran, V., Ledwith, M.P., Thamamongood, T. et al. Influenza virus repurposes the antiviral protein IFIT2 to promote translation of viral mRNAs. Nat Microbiol (2020).

Download citation


Sign up for the Nature Briefing newsletter for a daily update on COVID-19 science.
Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing